申请人:Agios Pharmaceuticals, Inc.
公开号:US20170283401A1
公开(公告)日:2017-10-05
Compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.